Products:Neuroscience >> Neurology process >> Neurodegenerative disease >> Alzheimer's disease >> Other
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »This product is covered by the Abpromise guarantee. Our scientific support team are available to answer any questions or queries - fill out an inquiry form for ab39163 for help.
Alternatively, you can search the previous enquiries about this product to see if your query has already been answered.
|
|||||||||
|
|||||||||
I have seen bands ~60kDa with ab39163, and from searching your website understand that these are due to n-terminal cleavage. What I wanted to know was whether or not it’s been shown exactly which portion of the protein this band represents (ie, is it just the cleaved pro-domain, which contains the activation site epitope, and if so is the mw high due to glycosylation, or is it a different cleavage product?). Thanks very much, |
|||||||||
ANSWER: |
Thank you very much for your inquiry. The amino end of ADAM-17 is processed by furin-like proteinases during maturation of the protein. The Carboxy end is also cleaved by different proteinases, and the amino end is further cleaved as well. The ab39163 ADAM-17 epitope is after the furin cleavage site, within the range of the catalytic domain. Most of the glycosylation occurs in the propeptide domain, so a larger than expected size might be ADAM-17 with intact carboxyterminus. This has not been experimentally tested. I hope this information is helpful. Please do not hesitate to contact me again with any further questions. |
||||||||
|
|||||||||
I have been using your rabbit polyclonal against the propeptide domain of ADAM17 to examine an ADAM17 prep and get no recognition with it at all whereas your other Abs (ab39163 and ab28233) are fine. I think my protein has been cleaved following Arg58 in the propeptide domain and I suspect that your Ab has been made against a peptide within the missing N-terminal 58 amino acids. Is this correct? Also, for the activation site Ab (ab39163) is only the intact site recognised or if after cleavage are both sides recognised or only one? |
|||||||||
ANSWER: |
you are correct in assuming that ab39161 recognizes only the prodomain cleaved during ADAM17 maturation. This maturation can be prevented using divalent metal chelators such as EDTA or EGTA. One of the customers who submitted an Abreview for ab39163 noted that "Seems to be selective for Precursor forms of ADAM17". The presence of the 55kDa band as well would indicate that both the cleaved and uncleaved form of this protein are recognized. |
||||||||
|
|||||||||
I have another question with your antibody ab39163, on your data sheet said "WB: Recommended starting dilution of 1/1000 (when using colorimetric substrates such as BCIP/NBT) and 1/5000 (for chemiluminescent substrates). Higher concentrations of antibody may be needed for samples from more distantly related species. Detects a band of approximately 120 kDa in reduced Western blots of conditioned media or cell lysates, which is converted to a 55-60 kDa band. (Predicted molecular weight: 93 kDa). Note: EDTA/EGTA treatment of tissues or lysates is required to see latent zymogen. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.". Why can 120kD become 55-60 kDa ? |
|||||||||
ANSWER: |
Thank you for your enquiry. Regarding the difference in detected molecular weight, glycosylation and other post-translational modifications increase the apparent molecular weight of ADAM 17 to 120 kDa, and cleavage at the aminoterminal end results in lower molecular weight forms, therefore producing the 55-60 kDa range. If there is anything else I can help you with, please do not hesitate to contact me. |
||||||||
|
|||||||||
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
The image shows ab39163 detecting mouse ADAM17 expressed in transfected HeLa cells. The cells were fixed in methanol and incubated with 10 µg/ml ab39163 for 1 hour at 20°C.
Image taken from anonymous Abreview submitted in February 2008
Anti-ADAM17 antibody - Activation site (ab39163) at 1/4000 dilution + MDA-MB231 lysate
Secondary
Donkey anti-Rabbit at 1/10000 dilution
Predicted band size : 93 kDa
ab39163 detected ADAM17 protein in lysates of the highly invasive human breast cancer cell line MDA-MB231. ab39163 was incubated at a dilution of 1/4000 for 16 hours at 4°C in PBS + 5% Milk. For further details please refer to the Abreview.
Image taken from an anonymous Abreview submitted in September 2007
Ab39163 staining human normal colon tissue. Staining is localised to cellular membranes.
Left panel: with primary antibody at 2 ug/ml. Right panel: isotype control.
Sections were stained using an automated system DAKO Autostainer Plus , at room temperature. Sections were rehydrated and antigen retrieved with the Dako 3-in-1 AR buffer EDTA pH 9.0 in a DAKO PT Link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 minutes. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 minutes and detected with Dako Envision Flex amplification kit for 30 minutes. Colorimetric detection was completed with diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.
2
Call 01223 696 000 or contact us